The clinical trial, conducted by Hideyuki Okano, a stem-cell scientist at Tokyo’s Keio University, involved four patients who were all paralyzed due to spinal cord injuries. The patients underwent an innovative treatment of neural stem cells to restore damaged spinal tissue and restore movement.
